ANN ARBOR, Mich., July 10 /PRNewswire/ -- QuatRx Pharmaceuticals Company announced today that it has withdrawn its initial public offering and its S-1 registration statement filed with the Securities and Exchange Commission (SEC) due to market conditions.
About QuatRx
QuatRx is a pharmaceutical company focused on discovering, licensing, developing and commercializing compounds in the endocrine, metabolic and cardiovascular therapeutic areas. QuatRx, founded in 2000, is headquartered in Ann Arbor, Michigan and has operations in Europe through Hormos Medical Ltd., a wholly-owned subsidiary located in Turku, Finland.
QuatRx Pharmaceuticals Company
CONTACT: Gary Onn of QuatRx Pharmaceuticals Company, +1-734-913-9900 x119
Web site: http://www.quatrx.com/
